US Broker Ratings

Cardinal Health, Inc. (CAH) Investor Outlook: Analyzing a 6.98% Potential Upside

As an established player in the healthcare sector, Cardinal Health, Inc. (NYSE: CAH) has carved a niche in the medical distribution industry. With a substantial market..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Potential with a 3.99% Upside

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable entity in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Biotech Innovator with a 3.21% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading figure in the biotechnology sector, is drawing significant attention from investors due to its innovative approach in developing ribonucleic..

Fresenius Medical Care AG (FMS) Stock Report: Navigating a 16.78% Potential Upside

Fresenius Medical Care AG (FMS), a leading player in the healthcare sector, primarily focuses on providing dialysis and related services to individuals with renal diseases. Headquartered..

Eli Lilly and Company (LLY) Stock Analysis: Exploring a Potential 20% Upside Amidst Strong Revenue Growth

Eli Lilly and Company (NYSE: LLY) stands as a towering figure in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of..

Cencora, Inc. (COR) Stock Analysis: Exploring a 9.47% Potential Upside for Investors

Cencora, Inc. (NYSE: COR) has been making waves in the healthcare sector, particularly within the medical distribution industry. With a market capitalization of $57.22 billion, Cencora..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Potential Upside of 64.89% Awaits Investors

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a stalwart in the biotechnology sector, is known for its relentless pursuit of therapies targeting life-threatening rare diseases. With a market..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Unveiling a 27.53% Potential Upside and Strong Buy Ratings

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a beacon in the healthcare sector, particularly in the diagnostics and research industry. With a substantial market capitalization..

Abbott Laboratories (ABT) Stock Analysis: Navigating Growth with a 7.04% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with its robust portfolio and promising growth metrics. With a market..

AstraZeneca PLC (AZN) Stock Analysis: Exploring an 18.35% Potential Upside Amid Robust Growth Prospects

AstraZeneca PLC (AZN), a titan in the healthcare sector, continues to capture investor attention with its impressive market capitalization of $223.9 billion and promising growth trajectory...

Align Technology, Inc. (ALGN) Stock Analysis: Potential Upside of 14.86% Amidst Industry Challenges

Align Technology, Inc. (NASDAQ: ALGN) stands as a prominent figure in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Quest Diagnostics (DGX) Stock Analysis: Is a 9.42% Upside Within Reach?

Quest Diagnostics Incorporated (NYSE: DGX) stands as a prominent player in the healthcare sector, particularly in diagnostics and research. With a substantial market cap of $18.76..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Deep Dive into Its 43% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA) is a prominent name within the healthcare sector, specifically among drug manufacturers specializing in both specialty and generic products. Based in..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Exploring a 22.74% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a notable player in the healthcare sector, continues to captivate investor attention with its robust business model and promising growth..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Analyzing the 12.39% Potential Upside

Investors with a keen eye on the healthcare sector will find Intuitive Surgical, Inc. (NASDAQ: ISRG) an intriguing prospect. With a market cap of $183.53 billion,..

GSK plc (GSK) Stock Analysis: Discovering Potential Upside in Healthcare Giant

GSK plc (NYSE: GSK) stands as a formidable player in the global healthcare sector, deeply embedded in drug manufacturing with a strong focus on vaccines, specialty..

Johnson & Johnson (JNJ) Stock Analysis: Exploring a 7.83% Potential Upside Amidst Robust Dividend Yield

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to hold a commanding presence with its expansive portfolio in both the Innovative Medicine..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 32% Potential Upside with Strong Buy Ratings

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves with its remarkable potential upside of 32.22%, as highlighted by analyst ratings...

BioNTech SE (BNTX) Stock Analysis: Exploring a Potential 21% Upside with Strong Buy Ratings

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology industry, has carved a niche for itself in the global healthcare landscape with its innovative immunotherapies..

Incyte Corporation (INCY) Stock Analysis: Strong Revenue Growth and Strategic Pipeline Bolster Investor Confidence

In the dynamic world of biotechnology, Incyte Corporation (NASDAQ: INCY) stands out as a formidable player, combining a robust pipeline with impressive revenue growth. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds